Director
Seres Therapeutics
Elizabeth Halvorsen is the Director of Host Biology in R&D at Seres Therapeutics. Dr. Halvorsen has a PhD in Microbiology from the University of Illinois, followed by postdoctoral research at Harvard Medical School in host-microbe interactions, and an industry postdoctoral fellow at Cubist Pharmaceuticals before joining Seres Therapeutics in 2015.